Viewing Study NCT05738694


Ignite Creation Date: 2025-12-25 @ 1:42 AM
Ignite Modification Date: 2026-02-27 @ 3:14 AM
Study NCT ID: NCT05738694
Status: RECRUITING
Last Update Posted: 2023-05-09
First Post: 2023-01-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant of Axitinib Plus PD-1 to Improve Disease Free Survival of Patients With Renal Cell Carcinoma
Sponsor: ZHOU FANGJIAN
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module